dilluns, 9 de març del 2015

Study: TAVI shows quality-of-life benefits, but not for everyone




Medtronic's CoreValve transcatheter aortic valve implant delivered "substantial" benefits in a study of extreme-risk patients, but a significant minority died or had "very poor" quality of life after TAVI, according to a study in Journal of the American College of Cardiology.





Study: TAVI shows quality-of-life benefits, but not for everyone

Journal of the American College of Cardiology, Medtronic

News Well, Clinical Trials, Replacement Heart Valves

read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1F2sQFb
a

Cap comentari:

Publica un comentari a l'entrada